BioCryst Pharma (BCRX) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $4.21 -3.88%
Revenue Growth %: +26.2%
Financial Fact:
Interest and other income: 109K
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: +26.2%
Financial Fact:
Interest and other income: 109K
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
BioCryst Pharma (NASDAQ: BCRX) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $4.3 million.
For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Towne Bank (TOWN) Reports In-Line Q1 EPS
- Towne Bank (TOWN) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
